nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—ABCB1—Lisinopril—systemic scleroderma	0.0725	0.218	CbGbCtD
Midazolam—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0657	0.197	CbGbCtD
Midazolam—ABCB1—Captopril—systemic scleroderma	0.0543	0.163	CbGbCtD
Midazolam—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0427	0.128	CbGbCtD
Midazolam—ABCB1—Prednisone—systemic scleroderma	0.0342	0.103	CbGbCtD
Midazolam—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0256	0.077	CbGbCtD
Midazolam—CYP3A4—Prednisone—systemic scleroderma	0.0205	0.0615	CbGbCtD
Midazolam—ABCB1—Methotrexate—systemic scleroderma	0.0171	0.0515	CbGbCtD
Midazolam—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00164	CcSEcCtD
Midazolam—Anxiety—Leflunomide—systemic scleroderma	0.00109	0.00164	CcSEcCtD
Midazolam—Osteoarthritis—Prednisone—systemic scleroderma	0.00109	0.00164	CcSEcCtD
Midazolam—Constipation—Captopril—systemic scleroderma	0.00109	0.00164	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00109	0.00163	CcSEcCtD
Midazolam—Tension—Lisinopril—systemic scleroderma	0.00109	0.00163	CcSEcCtD
Midazolam—Skin disorder—Azathioprine—systemic scleroderma	0.00108	0.00162	CcSEcCtD
Midazolam—Nervousness—Lisinopril—systemic scleroderma	0.00108	0.00161	CcSEcCtD
Midazolam—Affect lability—Prednisone—systemic scleroderma	0.00108	0.00161	CcSEcCtD
Midazolam—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00161	CcSEcCtD
Midazolam—Dry mouth—Leflunomide—systemic scleroderma	0.00107	0.00161	CcSEcCtD
Midazolam—Cough—Mycophenolic acid—systemic scleroderma	0.00107	0.00161	CcSEcCtD
Midazolam—Vomiting—Pentoxifylline—systemic scleroderma	0.00107	0.00161	CcSEcCtD
Midazolam—Psychotic disorder—Prednisone—systemic scleroderma	0.00107	0.0016	CcSEcCtD
Midazolam—Rash—Pentoxifylline—systemic scleroderma	0.00106	0.00159	CcSEcCtD
Midazolam—Dermatitis—Pentoxifylline—systemic scleroderma	0.00106	0.00159	CcSEcCtD
Midazolam—Headache—Pentoxifylline—systemic scleroderma	0.00106	0.00158	CcSEcCtD
Midazolam—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00106	0.00158	CcSEcCtD
Midazolam—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00105	0.00158	CcSEcCtD
Midazolam—Feeling abnormal—Captopril—systemic scleroderma	0.00105	0.00158	CcSEcCtD
Midazolam—Vision blurred—Lisinopril—systemic scleroderma	0.00104	0.00157	CcSEcCtD
Midazolam—Anxiety—Mycophenolic acid—systemic scleroderma	0.00104	0.00156	CcSEcCtD
Midazolam—Asthenia—Mometasone—systemic scleroderma	0.00104	0.00156	CcSEcCtD
Midazolam—Irritability—Prednisone—systemic scleroderma	0.00104	0.00156	CcSEcCtD
Midazolam—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00156	CcSEcCtD
Midazolam—Hypotension—Azathioprine—systemic scleroderma	0.00104	0.00156	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00104	0.00156	CcSEcCtD
Midazolam—Cardiac arrest—Prednisone—systemic scleroderma	0.00104	0.00156	CcSEcCtD
Midazolam—Tremor—Lisinopril—systemic scleroderma	0.00104	0.00156	CcSEcCtD
Midazolam—Mood swings—Prednisone—systemic scleroderma	0.00104	0.00155	CcSEcCtD
Midazolam—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00155	CcSEcCtD
Midazolam—Nervous system disorder—Leflunomide—systemic scleroderma	0.00103	0.00155	CcSEcCtD
Midazolam—Pruritus—Mometasone—systemic scleroderma	0.00103	0.00154	CcSEcCtD
Midazolam—Tachycardia—Leflunomide—systemic scleroderma	0.00103	0.00154	CcSEcCtD
Midazolam—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00102	0.00154	CcSEcCtD
Midazolam—Skin disorder—Leflunomide—systemic scleroderma	0.00102	0.00153	CcSEcCtD
Midazolam—Confusional state—Mycophenolic acid—systemic scleroderma	0.00101	0.00152	CcSEcCtD
Midazolam—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00151	CcSEcCtD
Midazolam—Nausea—Pentoxifylline—systemic scleroderma	0.001	0.0015	CcSEcCtD
Midazolam—Chills—Mycophenolate mofetil—systemic scleroderma	0.001	0.0015	CcSEcCtD
Midazolam—Vertigo—Lisinopril—systemic scleroderma	0.000996	0.00149	CcSEcCtD
Midazolam—Syncope—Lisinopril—systemic scleroderma	0.000994	0.00149	CcSEcCtD
Midazolam—Shock—Mycophenolic acid—systemic scleroderma	0.000988	0.00148	CcSEcCtD
Midazolam—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000985	0.00148	CcSEcCtD
Midazolam—Hypotension—Leflunomide—systemic scleroderma	0.000984	0.00147	CcSEcCtD
Midazolam—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00098	0.00147	CcSEcCtD
Midazolam—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000978	0.00146	CcSEcCtD
Midazolam—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000976	0.00146	CcSEcCtD
Midazolam—Cough—Lisinopril—systemic scleroderma	0.000967	0.00145	CcSEcCtD
Midazolam—Muscular weakness—Prednisone—systemic scleroderma	0.000964	0.00144	CcSEcCtD
Midazolam—Visual disturbance—Methotrexate—systemic scleroderma	0.000964	0.00144	CcSEcCtD
Midazolam—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000963	0.00144	CcSEcCtD
Midazolam—Tension—Mycophenolate mofetil—systemic scleroderma	0.000953	0.00143	CcSEcCtD
Midazolam—Paraesthesia—Leflunomide—systemic scleroderma	0.000946	0.00142	CcSEcCtD
Midazolam—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000944	0.00141	CcSEcCtD
Midazolam—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000943	0.00141	CcSEcCtD
Midazolam—Anxiety—Lisinopril—systemic scleroderma	0.000941	0.00141	CcSEcCtD
Midazolam—Dyspnoea—Leflunomide—systemic scleroderma	0.000939	0.00141	CcSEcCtD
Midazolam—Hypotension—Mycophenolic acid—systemic scleroderma	0.000939	0.00141	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000937	0.0014	CcSEcCtD
Midazolam—Lethargy—Methotrexate—systemic scleroderma	0.000932	0.0014	CcSEcCtD
Midazolam—Dyspepsia—Leflunomide—systemic scleroderma	0.000927	0.00139	CcSEcCtD
Midazolam—Vomiting—Mometasone—systemic scleroderma	0.000925	0.00139	CcSEcCtD
Midazolam—Dry mouth—Lisinopril—systemic scleroderma	0.000923	0.00138	CcSEcCtD
Midazolam—Feeling abnormal—Azathioprine—systemic scleroderma	0.000919	0.00138	CcSEcCtD
Midazolam—Rash—Mometasone—systemic scleroderma	0.000917	0.00137	CcSEcCtD
Midazolam—Asthenia—Captopril—systemic scleroderma	0.000917	0.00137	CcSEcCtD
Midazolam—Dermatitis—Mometasone—systemic scleroderma	0.000916	0.00137	CcSEcCtD
Midazolam—Osteoarthritis—Methotrexate—systemic scleroderma	0.000914	0.00137	CcSEcCtD
Midazolam—Confusional state—Lisinopril—systemic scleroderma	0.000912	0.00137	CcSEcCtD
Midazolam—Headache—Mometasone—systemic scleroderma	0.000911	0.00137	CcSEcCtD
Midazolam—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00091	0.00136	CcSEcCtD
Midazolam—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000909	0.00136	CcSEcCtD
Midazolam—Fatigue—Leflunomide—systemic scleroderma	0.000908	0.00136	CcSEcCtD
Midazolam—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000905	0.00136	CcSEcCtD
Midazolam—Pruritus—Captopril—systemic scleroderma	0.000904	0.00135	CcSEcCtD
Midazolam—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000902	0.00135	CcSEcCtD
Midazolam—Pain—Leflunomide—systemic scleroderma	0.0009	0.00135	CcSEcCtD
Midazolam—Constipation—Leflunomide—systemic scleroderma	0.0009	0.00135	CcSEcCtD
Midazolam—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000896	0.00134	CcSEcCtD
Midazolam—Somnolence—Mycophenolic acid—systemic scleroderma	0.000893	0.00134	CcSEcCtD
Midazolam—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00134	CcSEcCtD
Midazolam—Shock—Lisinopril—systemic scleroderma	0.00089	0.00133	CcSEcCtD
Midazolam—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000884	0.00132	CcSEcCtD
Midazolam—Tachycardia—Lisinopril—systemic scleroderma	0.000883	0.00132	CcSEcCtD
Midazolam—Skin disorder—Lisinopril—systemic scleroderma	0.000879	0.00132	CcSEcCtD
Midazolam—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000873	0.00131	CcSEcCtD
Midazolam—Irritability—Methotrexate—systemic scleroderma	0.000872	0.00131	CcSEcCtD
Midazolam—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000871	0.00131	CcSEcCtD
Midazolam—Feeling abnormal—Leflunomide—systemic scleroderma	0.000868	0.0013	CcSEcCtD
Midazolam—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000867	0.0013	CcSEcCtD
Midazolam—Fatigue—Mycophenolic acid—systemic scleroderma	0.000866	0.0013	CcSEcCtD
Midazolam—Mood swings—Methotrexate—systemic scleroderma	0.000866	0.0013	CcSEcCtD
Midazolam—Nausea—Mometasone—systemic scleroderma	0.000864	0.00129	CcSEcCtD
Midazolam—Ataxia—Methotrexate—systemic scleroderma	0.000859	0.00129	CcSEcCtD
Midazolam—Constipation—Mycophenolic acid—systemic scleroderma	0.000859	0.00129	CcSEcCtD
Midazolam—Pain—Mycophenolic acid—systemic scleroderma	0.000859	0.00129	CcSEcCtD
Midazolam—Cough—Mycophenolate mofetil—systemic scleroderma	0.000848	0.00127	CcSEcCtD
Midazolam—Hypotension—Lisinopril—systemic scleroderma	0.000846	0.00127	CcSEcCtD
Midazolam—Dizziness—Captopril—systemic scleroderma	0.000845	0.00127	CcSEcCtD
Midazolam—Depression—Prednisone—systemic scleroderma	0.00084	0.00126	CcSEcCtD
Midazolam—Urticaria—Leflunomide—systemic scleroderma	0.000837	0.00125	CcSEcCtD
Midazolam—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000828	0.00124	CcSEcCtD
Midazolam—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000826	0.00124	CcSEcCtD
Midazolam—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000824	0.00123	CcSEcCtD
Midazolam—Hypersensitivity—Azathioprine—systemic scleroderma	0.000822	0.00123	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000821	0.00123	CcSEcCtD
Midazolam—Paraesthesia—Lisinopril—systemic scleroderma	0.000812	0.00122	CcSEcCtD
Midazolam—Vomiting—Captopril—systemic scleroderma	0.000812	0.00122	CcSEcCtD
Midazolam—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000809	0.00121	CcSEcCtD
Midazolam—Dyspnoea—Lisinopril—systemic scleroderma	0.000807	0.00121	CcSEcCtD
Midazolam—Rash—Captopril—systemic scleroderma	0.000806	0.00121	CcSEcCtD
Midazolam—Dermatitis—Captopril—systemic scleroderma	0.000805	0.00121	CcSEcCtD
Midazolam—Somnolence—Lisinopril—systemic scleroderma	0.000804	0.00121	CcSEcCtD
Midazolam—Headache—Captopril—systemic scleroderma	0.0008	0.0012	CcSEcCtD
Midazolam—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000799	0.0012	CcSEcCtD
Midazolam—Dyspepsia—Lisinopril—systemic scleroderma	0.000796	0.00119	CcSEcCtD
Midazolam—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000793	0.00119	CcSEcCtD
Midazolam—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000781	0.00117	CcSEcCtD
Midazolam—Fatigue—Lisinopril—systemic scleroderma	0.00078	0.00117	CcSEcCtD
Midazolam—Shock—Mycophenolate mofetil—systemic scleroderma	0.00078	0.00117	CcSEcCtD
Midazolam—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000777	0.00116	CcSEcCtD
Midazolam—Hypersensitivity—Leflunomide—systemic scleroderma	0.000776	0.00116	CcSEcCtD
Midazolam—Pain—Lisinopril—systemic scleroderma	0.000774	0.00116	CcSEcCtD
Midazolam—Constipation—Lisinopril—systemic scleroderma	0.000774	0.00116	CcSEcCtD
Midazolam—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000774	0.00116	CcSEcCtD
Midazolam—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00077	0.00115	CcSEcCtD
Midazolam—Bradycardia—Prednisone—systemic scleroderma	0.00077	0.00115	CcSEcCtD
Midazolam—Nausea—Captopril—systemic scleroderma	0.000759	0.00114	CcSEcCtD
Midazolam—Asthenia—Leflunomide—systemic scleroderma	0.000756	0.00113	CcSEcCtD
Midazolam—Hallucination—Prednisone—systemic scleroderma	0.000753	0.00113	CcSEcCtD
Midazolam—Feeling abnormal—Lisinopril—systemic scleroderma	0.000746	0.00112	CcSEcCtD
Midazolam—Pruritus—Leflunomide—systemic scleroderma	0.000745	0.00112	CcSEcCtD
Midazolam—Connective tissue disorder—Prednisone—systemic scleroderma	0.000743	0.00111	CcSEcCtD
Midazolam—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000741	0.00111	CcSEcCtD
Midazolam—Dizziness—Azathioprine—systemic scleroderma	0.000737	0.0011	CcSEcCtD
Midazolam—Asthenia—Mycophenolic acid—systemic scleroderma	0.000721	0.00108	CcSEcCtD
Midazolam—Urticaria—Lisinopril—systemic scleroderma	0.000719	0.00108	CcSEcCtD
Midazolam—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000712	0.00107	CcSEcCtD
Midazolam—Pruritus—Mycophenolic acid—systemic scleroderma	0.000711	0.00106	CcSEcCtD
Midazolam—Vomiting—Azathioprine—systemic scleroderma	0.000709	0.00106	CcSEcCtD
Midazolam—Eye disorder—Prednisone—systemic scleroderma	0.000707	0.00106	CcSEcCtD
Midazolam—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000707	0.00106	CcSEcCtD
Midazolam—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000705	0.00106	CcSEcCtD
Midazolam—Drowsiness—Methotrexate—systemic scleroderma	0.000704	0.00106	CcSEcCtD
Midazolam—Rash—Azathioprine—systemic scleroderma	0.000703	0.00105	CcSEcCtD
Midazolam—Dermatitis—Azathioprine—systemic scleroderma	0.000702	0.00105	CcSEcCtD
Midazolam—Depression—Methotrexate—systemic scleroderma	0.000702	0.00105	CcSEcCtD
Midazolam—Headache—Azathioprine—systemic scleroderma	0.000699	0.00105	CcSEcCtD
Midazolam—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000698	0.00105	CcSEcCtD
Midazolam—Dizziness—Leflunomide—systemic scleroderma	0.000696	0.00104	CcSEcCtD
Midazolam—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000684	0.00103	CcSEcCtD
Midazolam—Immune system disorder—Prednisone—systemic scleroderma	0.000683	0.00102	CcSEcCtD
Midazolam—Pain—Mycophenolate mofetil—systemic scleroderma	0.000678	0.00102	CcSEcCtD
Midazolam—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000678	0.00102	CcSEcCtD
Midazolam—Vomiting—Leflunomide—systemic scleroderma	0.00067	0.001	CcSEcCtD
Midazolam—Hypersensitivity—Lisinopril—systemic scleroderma	0.000667	0.000999	CcSEcCtD
Midazolam—Dizziness—Mycophenolic acid—systemic scleroderma	0.000664	0.000995	CcSEcCtD
Midazolam—Rash—Leflunomide—systemic scleroderma	0.000664	0.000995	CcSEcCtD
Midazolam—Dermatitis—Leflunomide—systemic scleroderma	0.000663	0.000994	CcSEcCtD
Midazolam—Mental disorder—Prednisone—systemic scleroderma	0.000663	0.000993	CcSEcCtD
Midazolam—Nausea—Azathioprine—systemic scleroderma	0.000662	0.000992	CcSEcCtD
Midazolam—Headache—Leflunomide—systemic scleroderma	0.00066	0.000988	CcSEcCtD
Midazolam—Erythema—Prednisone—systemic scleroderma	0.000658	0.000987	CcSEcCtD
Midazolam—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000653	0.000979	CcSEcCtD
Midazolam—Asthenia—Lisinopril—systemic scleroderma	0.000649	0.000973	CcSEcCtD
Midazolam—Pruritus—Lisinopril—systemic scleroderma	0.00064	0.000959	CcSEcCtD
Midazolam—Vomiting—Mycophenolic acid—systemic scleroderma	0.000639	0.000957	CcSEcCtD
Midazolam—Rash—Mycophenolic acid—systemic scleroderma	0.000633	0.000949	CcSEcCtD
Midazolam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000633	0.000948	CcSEcCtD
Midazolam—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00063	0.000944	CcSEcCtD
Midazolam—Headache—Mycophenolic acid—systemic scleroderma	0.000629	0.000943	CcSEcCtD
Midazolam—Nausea—Leflunomide—systemic scleroderma	0.000625	0.000937	CcSEcCtD
Midazolam—Vision blurred—Prednisone—systemic scleroderma	0.000621	0.00093	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—systemic scleroderma	0.000609	0.000913	CcSEcCtD
Midazolam—Agitation—Prednisone—systemic scleroderma	0.000605	0.000907	CcSEcCtD
Midazolam—Dizziness—Lisinopril—systemic scleroderma	0.000598	0.000897	CcSEcCtD
Midazolam—Nausea—Mycophenolic acid—systemic scleroderma	0.000597	0.000894	CcSEcCtD
Midazolam—Vertigo—Prednisone—systemic scleroderma	0.000592	0.000886	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—systemic scleroderma	0.000591	0.000885	CcSEcCtD
Midazolam—Syncope—Prednisone—systemic scleroderma	0.00059	0.000885	CcSEcCtD
Midazolam—Cardiac disorder—Methotrexate—systemic scleroderma	0.000587	0.000879	CcSEcCtD
Midazolam—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000584	0.000875	CcSEcCtD
Midazolam—Vomiting—Lisinopril—systemic scleroderma	0.000575	0.000862	CcSEcCtD
Midazolam—Immune system disorder—Methotrexate—systemic scleroderma	0.000571	0.000856	CcSEcCtD
Midazolam—Rash—Lisinopril—systemic scleroderma	0.000571	0.000855	CcSEcCtD
Midazolam—Dermatitis—Lisinopril—systemic scleroderma	0.00057	0.000854	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00057	0.000854	CcSEcCtD
Midazolam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000569	0.000852	CcSEcCtD
Midazolam—Chills—Methotrexate—systemic scleroderma	0.000567	0.00085	CcSEcCtD
Midazolam—Headache—Lisinopril—systemic scleroderma	0.000567	0.000849	CcSEcCtD
Midazolam—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000561	0.00084	CcSEcCtD
Midazolam—Anxiety—Prednisone—systemic scleroderma	0.000559	0.000837	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000557	0.000834	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—systemic scleroderma	0.000554	0.00083	CcSEcCtD
Midazolam—Erythema—Methotrexate—systemic scleroderma	0.00055	0.000825	CcSEcCtD
Midazolam—Nausea—Lisinopril—systemic scleroderma	0.000537	0.000805	CcSEcCtD
Midazolam—Anaphylactic shock—Prednisone—systemic scleroderma	0.000537	0.000805	CcSEcCtD
Midazolam—Shock—Prednisone—systemic scleroderma	0.000529	0.000792	CcSEcCtD
Midazolam—Nervous system disorder—Prednisone—systemic scleroderma	0.000527	0.00079	CcSEcCtD
Midazolam—Tachycardia—Prednisone—systemic scleroderma	0.000524	0.000786	CcSEcCtD
Midazolam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000524	0.000786	CcSEcCtD
Midazolam—Skin disorder—Prednisone—systemic scleroderma	0.000522	0.000782	CcSEcCtD
Midazolam—Vision blurred—Methotrexate—systemic scleroderma	0.000519	0.000777	CcSEcCtD
Midazolam—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000755	CcSEcCtD
Midazolam—Rash—Mycophenolate mofetil—systemic scleroderma	0.0005	0.000749	CcSEcCtD
Midazolam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000499	0.000748	CcSEcCtD
Midazolam—Headache—Mycophenolate mofetil—systemic scleroderma	0.000497	0.000744	CcSEcCtD
Midazolam—Vertigo—Methotrexate—systemic scleroderma	0.000494	0.000741	CcSEcCtD
Midazolam—Paraesthesia—Prednisone—systemic scleroderma	0.000483	0.000723	CcSEcCtD
Midazolam—Cough—Methotrexate—systemic scleroderma	0.00048	0.00072	CcSEcCtD
Midazolam—Dyspepsia—Prednisone—systemic scleroderma	0.000473	0.000709	CcSEcCtD
Midazolam—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000471	0.000706	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000465	0.000697	CcSEcCtD
Midazolam—Fatigue—Prednisone—systemic scleroderma	0.000463	0.000694	CcSEcCtD
Midazolam—Constipation—Prednisone—systemic scleroderma	0.00046	0.000689	CcSEcCtD
Midazolam—Confusional state—Methotrexate—systemic scleroderma	0.000453	0.000679	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000449	0.000673	CcSEcCtD
Midazolam—Feeling abnormal—Prednisone—systemic scleroderma	0.000443	0.000664	CcSEcCtD
Midazolam—Nervous system disorder—Methotrexate—systemic scleroderma	0.00044	0.00066	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—systemic scleroderma	0.000436	0.000654	CcSEcCtD
Midazolam—Urticaria—Prednisone—systemic scleroderma	0.000427	0.00064	CcSEcCtD
Midazolam—Hypotension—Methotrexate—systemic scleroderma	0.00042	0.000629	CcSEcCtD
Midazolam—Paraesthesia—Methotrexate—systemic scleroderma	0.000403	0.000604	CcSEcCtD
Midazolam—Dyspnoea—Methotrexate—systemic scleroderma	0.0004	0.0006	CcSEcCtD
Midazolam—Somnolence—Methotrexate—systemic scleroderma	0.000399	0.000598	CcSEcCtD
Midazolam—Hypersensitivity—Prednisone—systemic scleroderma	0.000396	0.000593	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—systemic scleroderma	0.000395	0.000592	CcSEcCtD
Midazolam—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000388	0.000581	CcSEcCtD
Midazolam—Fatigue—Methotrexate—systemic scleroderma	0.000387	0.00058	CcSEcCtD
Midazolam—Asthenia—Prednisone—systemic scleroderma	0.000386	0.000578	CcSEcCtD
Midazolam—Pain—Methotrexate—systemic scleroderma	0.000384	0.000575	CcSEcCtD
Midazolam—Pruritus—Prednisone—systemic scleroderma	0.00038	0.00057	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—systemic scleroderma	0.00037	0.000555	CcSEcCtD
Midazolam—Urticaria—Methotrexate—systemic scleroderma	0.000357	0.000535	CcSEcCtD
Midazolam—Dizziness—Prednisone—systemic scleroderma	0.000355	0.000532	CcSEcCtD
Midazolam—Vomiting—Prednisone—systemic scleroderma	0.000342	0.000512	CcSEcCtD
Midazolam—Rash—Prednisone—systemic scleroderma	0.000339	0.000508	CcSEcCtD
Midazolam—Dermatitis—Prednisone—systemic scleroderma	0.000339	0.000507	CcSEcCtD
Midazolam—Headache—Prednisone—systemic scleroderma	0.000337	0.000504	CcSEcCtD
Midazolam—Hypersensitivity—Methotrexate—systemic scleroderma	0.000331	0.000496	CcSEcCtD
Midazolam—Asthenia—Methotrexate—systemic scleroderma	0.000322	0.000483	CcSEcCtD
Midazolam—Nausea—Prednisone—systemic scleroderma	0.000319	0.000478	CcSEcCtD
Midazolam—Pruritus—Methotrexate—systemic scleroderma	0.000318	0.000476	CcSEcCtD
Midazolam—Dizziness—Methotrexate—systemic scleroderma	0.000297	0.000445	CcSEcCtD
Midazolam—Vomiting—Methotrexate—systemic scleroderma	0.000286	0.000428	CcSEcCtD
Midazolam—Rash—Methotrexate—systemic scleroderma	0.000283	0.000424	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—systemic scleroderma	0.000283	0.000424	CcSEcCtD
Midazolam—Headache—Methotrexate—systemic scleroderma	0.000281	0.000422	CcSEcCtD
Midazolam—Nausea—Methotrexate—systemic scleroderma	0.000267	0.0004	CcSEcCtD
